Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker

Cancer is a systemic disease involving multiple components produced from both tumor cells themselves and surrounding stromal cells. The pro- or anti-tumoral role of the stroma is still under debate. Indeed, it has long been considered the main physical barrier to the diffusion of chemotherapy by its...

Descripción completa

Detalles Bibliográficos
Autores principales: Liot, Sophie, Aubert, Alexandre, Hervieu, Valérie, Kholti, Naïma El, Schalkwijk, Joost, Verrier, Bernard, Valcourt, Ulrich, Lambert, Elise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852205/
https://www.ncbi.nlm.nih.gov/pubmed/33543019
http://dx.doi.org/10.1016/j.mbplus.2020.100021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852205/
https://www.ncbi.nlm.nih.gov/pubmed/33543019
http://dx.doi.org/10.1016/j.mbplus.2020.100021

Ejemplares similares